Investors: Tie Pharma CEO Pay To Fair Global COVID-19 Vaccine Access
By Toby Sterling AMSTERDAM (Reuters) – A group of institutional investors representing $3.5 trillion in assets under management on Thursday called on pharmaceutical companies to link their executives’ pay to making COVID-19 vaccines available around the globe. While the majority of citizens of wealthy nations are vaccinated and many are now receiving booster shots, across…